A nurse in a provider's office is collecting data for a 45-year-old client who is having manifestations associated with perimenopause. Which of the following findings should the nurse expect?

A. "Dietary supplements have not been tested and approved by the government." While this statement may be true, it is not directly related to the potential interaction between dietary supplements and nitroglycerin.

B. "Dietary supplements may be expensive and are not typically covered by insurance." While cost considerations are important, they are not directly related to the potential interaction
between dietary supplements and nitroglycerin.
C. "There is not enough evidence that dietary supplements are effective for erectile dysfunction."
While this statement may be true, it is not directly related to the potential interaction between dietary supplements and nitroglycerin.
D. "Dietary supplements can cause a drug-drug interaction with nitrates." Nitroglycerin is a medication commonly used for angina, and it interacts with erectile dysfunction medications
such as sildenafil (Viagra) due to its vasodilatory effects, potentially causing severe hypotension.
Therefore, it is crucial for the nurse to educate the client about the risk of interactions between dietary supplements and nitroglycerin.

A. Menopause is the cessation of menstruation and marks the end of the reproductive years.
B. Menarche is the onset of menstruation and does not describe a phase of the menstrual cycle.
C. The follicular phase begins at the end of menses and ends at ovulation. During this phase, follicles in the ovaries mature, and one dominant follicle is selected for ovulation.
D. The luteal phase follows ovulation and ends with the start of menses. During this phase, the ruptured follicle transforms into the corpus luteum, which secretes progesterone to prepare the uterus for potential implantation of a fertilized egg.